Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12291709
Compositions and methods for modulating apolipoprotein (a) expression
granted -
US 12291058
Dispersions for additive manufacturing comprising discrete carbon nanotubes
granted -
US 12280093
Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative diabetic retinopathy
granted -
US 12281305
Compounds and methods for reducing prion expression
granted -
US 12281321
Frataxin expression constructs having engineered promoters and methods of use thereof
granted -
US 12274735
IL-4-fusion formulations for treatment of central nervous system (CNS) tumors
granted -
US 12275758
Prefusion RSV F proteins and their use
granted -
US 12268660
Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension
granted -
US 12259378
Dynamic clamps and methods of use thereof
granted -
US 12247226
Cellular reprogramming using temporal and transient plasmid vector expression system
granted -
US 12246059
Stable hybrid FC fusion G-CSF formulation
granted -
US 12241067
Compounds and methods for reducing LRRK2 expression
granted -
US 12233135
Therapeutic constructs for treating cancer
granted -
US 12232492
Disinfection of bacteriophages products using supercritical carbon dioxide
granted -
US 12228572
Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus (HIV)-infected cells
granted -
US 12226437
Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell
granted -
US 12227584
Multivalent and multispecific OX40-binding fusion proteins
granted -
US 12227744
Compositions and methods for inhibiting expression of transthyretin
granted -
US 12221610
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of use
granted -
US 12221483
Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 12215131
IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof
granted -
US 12214218
Perfusion modulated tumor dose sculpting with single dose radiotherapy
granted -
US 12208227
Precision bio-chemotronic system
granted -
US 12201673
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted